HCA

HCA Healthcare, Inc.NYSEHealthcare

$471.84-0.61%OpenMarket Cap: $105.51B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-10	TD Cowen	—	Buy	—
2026-02-25	Mizuho	—	Outperform	—
2026-02-23	UBS	—	Buy	—
2026-02-20	JP Morgan	—	Neutral	—
2026-02-06	Argus Research	—	Buy	—
2026-01-30	Wells Fargo	—	Equal Weight	—
2026-01-28	Deutsche Bank	—	Buy	—
2026-01-28	Keybanc	—	Overweight	—
2026-01-28	Oppenheimer	—	Outperform	—
2026-01-28	Cantor Fitzgerald	—	Overweight	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$33.30	$82.38B	16
Sun Dec 31	$37.30	$86.90B	7
Mon Dec 31	$42.58	$92.67B	2
Tue Dec 31	$49.36	$100.42B	5